Literature DB >> 30280759

MiR-203 is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis.

L Qiao1, D Liu, C-G Li, Y-J Wang.   

Abstract

OBJECTIVE: The purpose of this study was to investigate how miR-203 promotes osteogenic differentiation of bone marrow mesenchymal cells (BMSCs) by regulating its target gene DKK1, thereby inhibiting the occurrence of osteoporosis. PATIENTS AND METHODS: A total of 60 cases with postmenopausal osteoporosis and 40 cases of normal individuals were recruited. The expression of miR-203 in serum of all cases was detected by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The capacity of osteogenesis and adipogenic differentiation of MSCs was determined by alizarin red staining and oil red staining, respectively. Transfection of miR-203 mimics and miR-203 inhibitor were mediated by Liposomes, and then the MSCs were induced osteogenic and adipogenic differentiation. MiR-203 mimic was co-transfected with wild-type or mutant DKK1 for luciferase reporter gene detection. In the osteoporosis model of rats, the tibia was taken for micro-CT examination of bone mineral density (BMD) and bone volume/structural parameters (BV/TV), while the femur was taken for the measurement of absorption parameters (Ob.S)./BS) and the number of osteoclasts per circumference of bone (N.Oc/B.Pm).
RESULTS: The expression level of miR-203 was significantly lower in patients with postmenopausal osteoporosis than that in normal individuals. The osteogenic capacity of BMSCs in these patients was reduced, while their adipogenic capacity was enhanced. MiR-203 promoted the expression of osteogenic genes and inhibited that of adipogenic genes. Knockdown of miR-203 decreased the level of osteogenic related genes but increased that of adipogenic related genes, while overexpression of miR-203 led to the opposite results. Furthermore, miR-203 inhibited the protein expression of DKK1. In addition, bone density and bone volume/structural parameters were lower in ovariectomized rats than those in normal rats. Meanwhile, bone resorption parameters and the number of osteoclasts per bone circumference in ovariectomized rats were higher than those in normal rats.
CONCLUSIONS: MiR-203 can promote osteogenic differentiation of mesenchymal stem cells by downregulating the gene expression of DKK1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30280759     DOI: 10.26355/eurrev_201809_15906

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

Review 1.  Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events.

Authors:  Jiao Li; Lingyun Lu; Yi Liu; Xijie Yu
Journal:  J Mol Med (Berl)       Date:  2021-11-09       Impact factor: 4.599

Review 2.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

3.  miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis.

Authors:  Lubing Li; Xiahatai Ayiding; Ran Han
Journal:  Biomed Res Int       Date:  2022-06-15       Impact factor: 3.246

4.  MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA.

Authors:  Tao Yu; Xiaomeng You; Haichao Zhou; Wenbao He; Zihua Li; Bing Li; Jiang Xia; Hui Zhu; Youguang Zhao; Guangrong Yu; Yuan Xiong; Yunfeng Yang
Journal:  Aging (Albany NY)       Date:  2020-05-19       Impact factor: 5.682

5.  Regulation of osteogenesis via miR-101-3p in mesenchymal stem cells by human gingival fibroblasts.

Authors:  Eri Kaneda-Ikeda; Tomoyuki Iwata; Noriyoshi Mizuno; Takayoshi Nagahara; Mikihito Kajiya; Kazuhisa Ouhara; Minami Yoshioka; Shu Ishida; Hiroyuki Kawaguchi; Hidemi Kurihara
Journal:  J Bone Miner Metab       Date:  2020-01-23       Impact factor: 2.626

6.  TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation.

Authors:  De-Bo Zou; Zongyou Mou; Wenliang Wu; Haichun Liu
Journal:  Aging Cell       Date:  2021-06-08       Impact factor: 9.304

Review 7.  Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects.

Authors:  Noha Attia; Mohamed Mashal; Gustavo Puras; Jose Luis Pedraz
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

Review 8.  Small and Long Non-coding RNAs as Functional Regulators of Bone Homeostasis, Acting Alone or Cooperatively.

Authors:  Mateusz Sikora; Krzysztof Marycz; Agnieszka Smieszek
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

Review 9.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

Review 10.  Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk?

Authors:  Simone Ciuffi; Simone Donati; Francesca Marini; Gaia Palmini; Ettore Luzi; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.